UKVIA reinforces call for “get tough” measures to stem rising numbers of children vaping

RegulationsMarket
Jul.12.2022
“However, there is an important role for industry, regulators, the education sector and enforcement bodies to collaborate to ensure that vapes do not fall into the wrong hands.”

 UKVIA reinforces call for “get tough” measures to stem rising numbers of children vaping

  • Association says unscrupulous retailers to blame for increase but acknowledges part that “industry, regulators, the education sector and enforcement bodies” can play collectively in preventing youth access
  • New figures from Action on Smoking and Health (ASH), highlighting the rise in use of vapes amongst U18 year olds, follow a range of robust measures proposed by the UKVIA to the Department for Health and Social Care last week designed to stamp out rogue trading
UKVIA reinforces call for “get tough” measures to stem rising numbers of children vaping

The UK Vaping Industry Association (UKVIA), the largest trade body representing the vaping industry, has reinforced its call for a range of get-tough measures to crack down on unscrupulous retailers who sell vapes to young people, including fines of £10k and a national retail licencing scheme.

It comes as a survey from Action on Smoking and Health (ASH) found that the proportion of children aged 11-17 who vape has risen from 4% in 2020 to 7% this year. It also found that disposable vapes are the most popular products among 52% of underaged vapers.

Responding to the report, the UKVIA’s Director General John Dunne said: “The UKVIA understands the need for the right balance between supporting adult smokers to quit without encouraging take up amongst under-18s and ‘never-smokers’.

“We wrote to the Department for Health and Social Care last week to address the issue of child access to vapes, proposing a set of recommendations to come down hard on those who sell vapes to minors whilst maintaining vaping’s critical role for helping smokers to quit.”

Its proposed recommendations included:

  • The introduction of a licensing or approved retailer and distributor scheme whereby vape retailers (both online and in-store) and distributors on the scheme would pay a fee, adhere to strong age verification practices and commit that products they sell are both notified with the Medicines and Healthcare products Regulatory Agency (MHRA) and compliant with Classification, Labelling and Packaging (CLP) Regulation.
  • Serving increased penalties of at least £10,000 per instance on traders flouting UK law. Should two fines be issued, a retailer would lose its ‘approved retailer’ status.
  • Commission a national test purchasing scheme similar to the one the UKVIA runs for its members to ensure all operations are performing to high standards when it comes to preventing youth access to e-cigarettes.
  • Ensure Trading Standards is effectively resourced, such that it can recruit and train officers, dispose of illicit products, and ensure its actions are an effective deterrent to rogue actors across the supply chain. Such funding would be sourced from the proposed licensing scheme and, eventually, from fines issued for illegal trading.
  • Adopt into legislation the UKVIA’s packaging, labelling and flavour names guidelines to prevent against branding that inadvertently appeals to non-smokers or under-18s. These guidelines reflect recommendations from the Khan Review.
  • Introduce non-nicotine containing e-liquids to the Tobacco and Related Products Regulations (TRPR). Regulating all e-liquids in this way will further bear down on youth access and improve the quality of products offered for sale.

 

“Together, these actions will help vaping fulfil the vital role that the recently published Khan review sees for the category in making smoking obsolete in the most responsible manner,” continued John Dunne.

 

“Our members work to strict supply chain and packaging, labelling and flavour name guidelines, but more is needed to bear down on rogue traders outside our membership who flout the law and have no qualms about selling vapes to minors,” he added.

“Make no mistake, the issue of youth access to vaping sits firmly with unscrupulous traders who are happy to sell to children. To combat rising numbers of children vaping, the supply of vapes to the underaged has to be cut off at source.

 

“However, there is an important role for industry, regulators, the education sector and enforcement bodies to collaborate to ensure that vapes do not fall into the wrong hands.”

 

The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the author and refrain from forwarding directly from here.

PMI Plans $71 Million Philippine Smoke-Free Expansion: BLENDS Production Established, Batangas Plant Exports to 18 Markets
PMI Plans $71 Million Philippine Smoke-Free Expansion: BLENDS Production Established, Batangas Plant Exports to 18 Markets
Philip Morris International (PMI) plans to invest approximately PHP 4.5 billion ($71 million) to expand its existing smoke-free manufacturing facility in Tanauan, Batangas, in the Philippines. The expansion is expected to be completed in 2027, with additional capacity serving domestic and export markets. The facility began manufacturing heated tobacco consumables in April 2024, including BLENDS sticks for the BONDS by IQOS platform. Philippine business media reported in October 2026 that products from the Batangas plant were being exported to 18 markets across Asia and Europe. PMI says it has invested more than $2 billion in the Philippines since 2010. The expansion adds to the country's existing manufacturing and export role within PMI's international supply chain.
company
Nov.16
AIR Q3 Sales Rise 11%, but New Products Generate Just $2.1 Million in Nine Months as U.S. Vape Push Awaits FDA Review
AIR Q3 Sales Rise 11%, but New Products Generate Just $2.1 Million in Nine Months as U.S. Vape Push Awaits FDA Review
AIR Global PLC (NASDAQ: AIIR), a producer of flavored shisha tobacco and next-generation nicotine products, reported an 11.1% increase in third-quarter 2026 revenue to $99.8 million and a 7.7% rise in adjusted EBITDA to $30.9 million. Revenue for the first nine months increased 6.0% to $306.7 million, but the company posted a $74.2 million net loss, affected by listing-related expenses and other costs. Its New Growth Categories (NGC) business generated $2.1 million in nine-month revenue and an adjusted EBITDA loss of $10.8 million. AIR maintained its 2026 revenue growth guidance of 4%–6%, while lowering its capital expenditure outlook and raising its year-end leverage forecast from approximately 2.1 times to 2.5 times. The company has submitted a U.S. PMTA for its Crown Switch pod vape, with future contributions from new products dependent on regulatory progress and commercialization.
Capital Markets
Nov.13
Product | KIWI Launches Spark 2 and Spark 2 Pro in Germany, Two Hardware Tiers Share Backward-Compatible 2ml Pods
Product | KIWI Launches Spark 2 and Spark 2 Pro in Germany, Two Hardware Tiers Share Backward-Compatible 2ml Pods
KIWI has launched the Spark 2 and Spark 2 Pro refillable pod systems in Germany at official prices of €18 and €29, respectively. Spark 2 uses an 800mAh removable lithium-ion battery in a pen-style body, while Spark 2 Pro features a 1,400mAh removable battery, a box-shaped design and vibration feedback every 20 puffs. Both devices use the same 2ml Spark V2 pods in 0.8Ω and 1.2Ω versions, with AirSync airflow adjustment and a choice between Cotton Tips and conventional Drip Tips. The new pods also remain compatible with the original KIWI Spark.
News
Sep.29 by 2Firsts Perspectives
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25